These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29332922)

  • 41. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.
    Osadnik T; Strzelczyk JK; Fronczek M; Bujak K; Reguła R; Gonera M; Gawlita M; Kurek A; Wasilewski J; Lekston A; Gierlotka M; Hawranek M; Ostrowska Z; Wiczkowski A; Poloński L; Gąsior M
    Adv Med Sci; 2016 Sep; 61(2):276-281. PubMed ID: 27162064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
    Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease.
    Chou HT; Chen CH; Tsai CH; Tsai FJ
    Am Heart J; 2004 Jul; 148(1):181-6. PubMed ID: 15215809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen receptor-alpha polymorphisms and angiographic outcome after coronary artery stenting.
    Ferrero V; Ribichini F; Matullo G; Guarrera S; Carturan S; Vado A; Vassanelli C; Piazza A; Uslenghi E; Wijns W
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2223-8. PubMed ID: 14563649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
    Zhao C; Yang L; Mao L; Zhong L; Li X; Wei S
    Coron Artery Dis; 2013 Aug; 24(5):357-60. PubMed ID: 23835667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relationship of interleukin-10 gene polymorphism with restenosis after percutaneous coronary intervention in Chinese].
    Gao J; Cui RZ; Liu Y; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM; Liu T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):42-6. PubMed ID: 21287508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
    Cheng G; Chang FJ; Wang Y; You PH; Chen HC; Han WQ; Wang JW; Zhong NE; Min ZQ
    Med Sci Monit; 2019 Jan; 25():240-247. PubMed ID: 30617247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
    Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
    Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
    Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
    Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The association between polymorphism of transforming growth factor-β1 and radiochemotherapy response and survival in esophageal squamous cell carcinoma patients].
    Zhou YL; Zhang WC; Chen XB; Xiao ZF; Qiao Y; Yu DK; Lin DX; Tan W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):583-7. PubMed ID: 22041558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement.
    von Beckerath N; Kastrati A; Koch W; Böttiger C; Mehilli J; Seyfarth M; Schömig A
    Atherosclerosis; 2000 Mar; 149(1):151-5. PubMed ID: 10704626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of interleukin-6 and transforming growth factor-beta1 in predicting restenosis within stented infarct-related artery.
    Szkodzinski J; Blazelonis A; Wilczek K; Hudzik B; Romanowski W; Gasior M; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
    Int J Immunopathol Pharmacol; 2009; 22(2):493-500. PubMed ID: 19505401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and association of the single nucleotide polymorphisms, C-509T, C+466T and T+869C, of the TGF-β1 gene in patients with asthma and their influence on the mRNA expression level of TGF-β1.
    Panek M; Pietras T; Fabijan A; Zioło J; Wieteska L; Małachowska B; Fendler W; Szemraj J; Kuna P
    Int J Mol Med; 2014 Oct; 34(4):975-86. PubMed ID: 25119113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
    Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
    J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
    Li M; Hou J; Gu X; Weng R; Zhong Z; Liu S
    Eur J Med Res; 2022 Jan; 27(1):12. PubMed ID: 35065663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Akyel A; Mendi MA; Oksuz F
    Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.
    Pleva L; Kusnierova P; Plevova P; Zapletalova J; Karpisek M; Faldynova L; Kovarova P; Kukla P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):586-94. PubMed ID: 26365933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-β1 and plasminogen activator inhibitor 1.
    Li XX; Li N; Ban CJ; Zhu M; Xiao B; Dai HP
    Chin Med J (Engl); 2011 Jul; 124(13):1923-7. PubMed ID: 22088447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.